It is only after migrating to the tumor microenvironment and receiving additional co-stimulatory signals and cytokine stimuli that these precursor cells differentiate into fully functional effector CD8+ T cells, acquiring the capacity to kill tumor cells. This evidence concerns the gene CD8A and neoplasm.